81
edits
Supply Chain Issues: Difference between revisions
no edit summary
No edit summary |
No edit summary |
||
| Line 67: | Line 67: | ||
''' | ''' | ||
Routine vaccines, such as flu vaccines, were in short supply due to the focus and attention shifting to COVID-19 vaccine production. | Routine vaccines, such as flu vaccines, were in short supply due to the focus and attention shifting to COVID-19 vaccine production. | ||
===Long-term Changes in Medical Supply Chains=== | |||
Different countries responded to the pandemic with varying levels of leadership, governance, and preparedness. Public health measures and government communication also differed significantly. The pandemic is leading to changes in how supplies are produced and distributed based on what was learned from these varied approaches. Regulatory frameworks are adapting to factor in precaution and to allow more flexibility in future crises. | |||
There is also learning from from successful initiatives, such as Singapore’s national stockpile of PPE and medical products to last for up to 6 months, drawing on the lessons learned when responding to the SARS (Severe Acute Respiratory Syndrome) outbreak in 2003 <ref>Chua, A. Q. et al. Health system resilience in managing the COVID-19 pandemic: lessons from Singapore. BMJ Glob. Health 5, e003317 (2020). https://gh.bmj.com/content/5/9/e003317 </ref> | |||
==Citations== | ==Citations== | ||
<references/> | <references/> | ||